Technical Analysis for TPST - Tempest Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.28% | |
Calm After Storm | Range Contraction | -2.28% | |
NR7 | Range Contraction | -2.28% | |
Narrow Range Bar | Range Contraction | -2.28% | |
Inside Day | Range Contraction | -2.28% | |
Wide Bands | Range Expansion | -2.28% |
Alert | Time |
---|---|
Possible NR7 | about 6 hours ago |
Down 5% | about 7 hours ago |
60 Minute Opening Range Breakdown | about 8 hours ago |
Down 3% | about 8 hours ago |
Non-ADX 1,2,3,4 Bearish Retracement Entry | about 10 hours ago |
Get a Trading Assistant
- Earnings date: 08/08/2024
Tempest Therapeutics, Inc. Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company's two novel clinical programs are TPST-1495 and TPST-1120, antagonists of EP2/EP4 and PPARa. Its TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study agents as monotherapies and in combination with other approved agents. The company is also developing an orally-available inhibitor of TREX-1 designed to activate selectively the cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity. The company is headquartered in South San Francisco, California. Tempest Therapeutics Inc. operates as a subsidiary of Inception Sciences, Inc.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Tumor
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.0 |
52 Week Low | 0.17 |
Average Volume | 1,076,173 |
200-Day Moving Average | 3.40 |
50-Day Moving Average | 3.12 |
20-Day Moving Average | 2.71 |
10-Day Moving Average | 2.26 |
Average True Range | 0.22 |
RSI (14) | 27.54 |
ADX | 28.9 |
+DI | 13.19 |
-DI | 33.68 |
Chandelier Exit (Long, 3 ATRs) | 3.00 |
Chandelier Exit (Short, 3 ATRs) | 2.52 |
Upper Bollinger Bands | 3.74 |
Lower Bollinger Band | 1.69 |
Percent B (%b) | 0.22 |
BandWidth | 75.69 |
MACD Line | -0.33 |
MACD Signal Line | -0.28 |
MACD Histogram | -0.0481 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.29 | ||||
Resistance 3 (R3) | 2.29 | 2.23 | 2.27 | ||
Resistance 2 (R2) | 2.23 | 2.20 | 2.24 | 2.26 | |
Resistance 1 (R1) | 2.19 | 2.17 | 2.16 | 2.19 | 2.25 |
Pivot Point | 2.13 | 2.13 | 2.12 | 2.14 | 2.13 |
Support 1 (S1) | 2.09 | 2.10 | 2.06 | 2.09 | 2.03 |
Support 2 (S2) | 2.03 | 2.07 | 2.04 | 2.02 | |
Support 3 (S3) | 1.99 | 2.03 | 2.02 | ||
Support 4 (S4) | 1.99 |